Compass Therapeutics Inc.
NASDAQ:CMPX
Income Statement
Earnings Waterfall
Compass Therapeutics Inc.
Income Statement
Compass Therapeutics Inc.
| Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||||||||||||||||
| Interest Expense |
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
1
N/A
|
1
N/A
|
1
N/A
|
0
N/A
|
0
N/A
|
|
| Operating Income | ||||||||||||||||||||||||
| Operating Expenses |
(34)
|
(29)
|
(26)
|
(26)
|
(28)
|
(29)
|
(80)
|
(77)
|
(82)
|
(82)
|
(35)
|
(42)
|
(42)
|
(44)
|
(49)
|
(48)
|
(50)
|
(53)
|
(56)
|
(56)
|
(57)
|
(50)
|
(53)
|
|
| Selling, General & Administrative |
(12)
|
(11)
|
(10)
|
(13)
|
(13)
|
(14)
|
(14)
|
(11)
|
(11)
|
(11)
|
(12)
|
(12)
|
(12)
|
(12)
|
(12)
|
(12)
|
(12)
|
(12)
|
(14)
|
(15)
|
(15)
|
(12)
|
(11)
|
|
| Research & Development |
(22)
|
(18)
|
(16)
|
(14)
|
(15)
|
(16)
|
(66)
|
(66)
|
(71)
|
(71)
|
(23)
|
(30)
|
(30)
|
(32)
|
(37)
|
(36)
|
(38)
|
(41)
|
(42)
|
(42)
|
(42)
|
(38)
|
(42)
|
|
| Operating Income |
(34)
N/A
|
(29)
+14%
|
(26)
+12%
|
(26)
-2%
|
(28)
-6%
|
(29)
-5%
|
(80)
-173%
|
(77)
+4%
|
(82)
-7%
|
(82)
+0%
|
(35)
+57%
|
(42)
-19%
|
(42)
+0%
|
(44)
-6%
|
(49)
-10%
|
(48)
+1%
|
(50)
-5%
|
(53)
-6%
|
(55)
-3%
|
(55)
-1%
|
(57)
-2%
|
(50)
+12%
|
(53)
-7%
|
|
| Pre-Tax Income | ||||||||||||||||||||||||
| Interest Income Expense |
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(0)
|
(0)
|
(0)
|
0
|
1
|
2
|
4
|
6
|
7
|
8
|
8
|
8
|
8
|
7
|
5
|
4
|
|
| Gain/Loss on Disposition of Assets |
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Other Income |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
0
|
|
| Pre-Tax Income |
(35)
N/A
|
(30)
+13%
|
(27)
+11%
|
(28)
-2%
|
(29)
-6%
|
(31)
-3%
|
(81)
-165%
|
(78)
+4%
|
(82)
-6%
|
(82)
+0%
|
(35)
+58%
|
(41)
-17%
|
(39)
+3%
|
(40)
-2%
|
(43)
-7%
|
(41)
+5%
|
(42)
-4%
|
(45)
-7%
|
(47)
-4%
|
(48)
-1%
|
(49)
-3%
|
(45)
+8%
|
(49)
-8%
|
|
| Net Income | ||||||||||||||||||||||||
| Tax Provision |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Income from Continuing Operations |
(35)
|
(30)
|
(27)
|
(28)
|
(30)
|
(31)
|
(81)
|
(78)
|
(82)
|
(82)
|
(35)
|
(41)
|
(39)
|
(40)
|
(43)
|
(41)
|
(42)
|
(45)
|
(47)
|
(48)
|
(49)
|
(45)
|
(49)
|
|
| Net Income (Common) |
(35)
N/A
|
(30)
+13%
|
(27)
+11%
|
(28)
-2%
|
(30)
-6%
|
(31)
-3%
|
(81)
-165%
|
(78)
+4%
|
(82)
-6%
|
(82)
+0%
|
(35)
+58%
|
(41)
-17%
|
(39)
+3%
|
(40)
-2%
|
(43)
-7%
|
(41)
+5%
|
(42)
-4%
|
(45)
-7%
|
(47)
-4%
|
(48)
-1%
|
(49)
-3%
|
(45)
+8%
|
(49)
-8%
|
|
| EPS (Diluted) |
-0.67
N/A
|
-0.58
+13%
|
-0.52
+10%
|
-0.54
-4%
|
-0.96
-78%
|
-0.59
+39%
|
-1.55
-163%
|
-1.25
+19%
|
-1.31
-5%
|
-0.81
+38%
|
-0.34
+58%
|
-0.42
-24%
|
-0.37
+12%
|
-0.31
+16%
|
-0.33
-6%
|
-0.33
N/A
|
-0.33
N/A
|
-0.33
N/A
|
-0.36
-9%
|
-0.36
N/A
|
-0.36
N/A
|
-0.33
+8%
|
-0.29
+12%
|
|